GURU.Markets stock price, segment price, and overall market index valuation
The company's share price PEN
Penumbra is a medical device company specializing in innovative devices for the treatment of stroke and other vascular diseases. Its stock price reflects demand for its minimally invasive technologies, which save lives and improve treatment outcomes.
Share prices of companies in the market segment - Therapeutic medical equipment
Penumbra is a company that produces medical equipment for the treatment of stroke and other vascular diseases. We classify it as a therapeutic medical device. The graph below shows the overall dynamics of this sector, driven by innovation and an aging population.
Broad Market Index - GURU.Markets
Penumbra is an innovative medical device company that develops and manufactures devices for the treatment of strokes, aneurysms, and other vascular diseases. As a key player in the healthcare sector, it is included in the GURU.Markets index. The chart below compares its performance to the overall US market.
Change in the price of a company, segment, and market as a whole per day
PEN - Daily change in the company's share price PEN
The daily price change for Penumbra, a manufacturer of innovative medical devices for neuro- and vascular surgery, is a measure of its volatility. While the chart of these fluctuations is unspectacular, it is an important component of the formulas on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - Therapeutic medical equipment
Penumbra, Inc. is a company in the medical device sector. This chart shows the average daily volatility of the MedTech industry. Comparing it to PEN, which focuses on stroke and thromboembolism treatments, helps assess whether its innovative products make it more or less volatile than the sector.
Daily change in the price of a broad market stock, index - GURU.Markets
Penumbra is an innovative medical technology company developing devices to treat stroke and other vascular diseases. The medical technology market is growing rapidly. The chart below shows the volatility in this sector, helping to assess how Penumbra shares are responding to innovation.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization PEN
Penumbra is a manufacturer of innovative medical devices for the treatment of stroke and other vascular diseases. Its year-over-year performance reflects rapid growth and the adoption of its technologies in clinical practice. The chart below tells the story of this medtech leader.
Annual dynamics of market capitalization of the market segment - Therapeutic medical equipment
Penumbra, Inc. is an innovative medical device company specializing in devices for the treatment of stroke and other vascular diseases. Its breakthrough technologies are transforming treatment approaches. This chart shows how its focus on these critical and rapidly growing areas of medicine allows it to stay ahead of the industry.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Penumbra is a company that produces innovative medical devices for the treatment of strokes and other vascular diseases. Its growth is driven by the implementation of its advanced technologies into clinical practice. Its stock price reflects this non-cyclical trend in healthcare.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization PEN
Penumbra develops innovative medical devices for the treatment of strokes and other vascular diseases. Sharp monthly fluctuations in the chart are often associated with news about clinical trials, new product approvals, and data on increased hospital use.
Monthly dynamics of market capitalization of the market segment - Therapeutic medical equipment
This chart illustrates the dynamics of the medical technology sector, particularly in neurosurgery. For Penumbra, one of the leaders, this provides context. Its movements reflect demand for its innovative devices for treating stroke and other vascular diseases.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Penumbra develops and markets innovative medical devices for the treatment of stroke and other vascular diseases. As a medtech company, it is less dependent on economic cycles. Despite the market fluctuations shown in the chart, Penumbra's performance is determined primarily by the successful launch of new products and their acceptance by the medical community.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization PEN
Penumbra produces medical equipment for the treatment of strokes and other vascular diseases. Weekly stock performance is highly sensitive to news of new product approvals, clinical trial results, and changes in physician practices.
Weekly dynamics of market capitalization of the market segment - Therapeutic medical equipment
Penumbra is a manufacturer of innovative medical equipment for stroke treatment. Comparing its weekly performance with the medical equipment sector reveals how investors value its products. Graรกfico allows you to see how news about new technologies is causing its shares to outperform their more conservative peers.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Shares of Penumbra, an innovative medical company, can live in a world of their own. Their performance is often driven by product news and clinical data. A chart comparing the stock to the S&P 500 clearly demonstrates how the stock can rise or fall, completely ignoring the broader market.
Market capitalization of the company, segment and market as a whole
PEN - Market capitalization of the company PEN
Penumbra's market capitalization chart tells the story of innovation in the treatment of stroke and other vascular diseases. The price dynamics of this medical device manufacturer reflect investors' faith in its technologies for thrombectomy and other minimally invasive procedures. It's a visualization of how breakthrough medical devices can change treatment standards and conquer the market.
PEN - Share of the company's market capitalization PEN within the market segment - Therapeutic medical equipment
Penumbra develops and manufactures innovative medical devices for the treatment of stroke and other vascular diseases. The company's market share in the medical devices sector reflects its leadership in neuro- and vascular interventional medicine. The chart below shows the impact this technological pioneer has on saving lives.
Market capitalization of the market segment - Therapeutic medical equipment
Penumbra develops and manufactures innovative medical devices for the treatment of strokes and other vascular diseases. The chart below shows the overall market capitalization of the medical equipment sector. Its growth reflects an aging population and the demand for new life-saving technologies, which drives Penumbra's business.
Market capitalization of all companies included in a broad market index - GURU.Markets
This chart shows the front lines in the fight against strokes. Penumbra develops innovative medical devices for neurosurgery. Its market cap reflects breakthroughs in medicine. The graph demonstrates how high-tech lifesaving solutions create significant economic value.
Book value capitalization of the company, segment and market as a whole
PEN - Book value capitalization of the company PEN
Penumbra's capital consists of its R&D centers, manufacturing facilities for innovative medical devices (for example, for stroke treatment), and a patent portfolio. This represents a knowledge-intensive resource base. The chart shows how investments in the development and commercialization of new technologies have generated capital that saves patients' lives.
PEN - Share of the company's book capitalization PEN within the market segment - Therapeutic medical equipment
Penumbra creates innovative medical devices to combat strokes and blood clots. Its strength is based on its own R&D centers and sterile manufacturing facilities. The chart shows the share of the high-tech physical infrastructure for medical device production in its niche that the company controls.
Market segment balance sheet capitalization - Therapeutic medical equipment
Penumbra, a medical device manufacturer, is a capital-intensive business. It requires clean rooms and sophisticated equipment to create its innovative catheters. The BCap_Seg chart for the medical device sector shows that success requires a robust manufacturing base.
Book value of all companies included in the broad market index - GURU.Markets
Penumbra's balance sheet consists of high-tech manufacturing facilities and laboratories where innovative medical devices for stroke treatment are created. The company's assets are the physical embodiment of its scientific and manufacturing potential. The chart shows the material weight of this medical equipment manufacturer.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - PEN
Penumbra's balance sheet is its high-tech factories. But the market pays a hefty premium for its innovative stroke treatment devices, its patents, and its growth potential in a huge market. The chart represents investors' bet that its technologies will save more lives and generate greater profits.
Market to book capitalization ratio in a market segment - Therapeutic medical equipment
Penumbra produces innovative medical devices for the treatment of strokes and other vascular diseases. Its high market valuation is driven by patents and unique technologies, not by production capacity. The chart shows the intellectual property premium in the MedTech sector.
Market to book capitalization ratio for the market as a whole
Penumbra produces innovative medical equipment for the treatment of strokes and other vascular diseases. The company's value lies in its patents and technologies, not its production capacity. This results in a market valuation that is a multiple of its book value, reflecting the demand for its vital products.
Debts of the company, segment and market as a whole
PEN - Company debts PEN
Penumbra, a medical device company for neurological and vascular surgery, uses debt to fund R&D and expand its commercial infrastructure. In the MedTech sector, innovation and rapid time-to-market are critical. This chart shows how the company invests in the development of new life-saving technologies while managing its debt.
Market segment debts - Therapeutic medical equipment
Penumbra develops and manufactures innovative medical devices, particularly for stroke treatment. In the MedTech sector, debt can be used to finance costly clinical trials and bring new products to market. This chart shows how the company balances investment in R&D with maintaining financial stability for long-term growth.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio PEN
Penumbra develops and manufactures innovative medical devices, such as those for stroke treatment. This process requires significant investment in research. The chart shows how the company finances its growth. Low debt may indicate a strong market position and the ability to fund R&D from operating profits.
Market segment debt to market segment book capitalization - Therapeutic medical equipment
Penumbra develops and manufactures innovative medical devices, particularly for stroke treatment. The medical device sector requires significant investment in research and clinical trials. The chart shows how the company's debt load for R&D funding compares to the overall market capitalization of the industry.
Debt to book value of all companies in the market
Penumbra, a medical device manufacturer, invests in R&D to create innovative products. This chart places these investments in a broader economic context, comparing the company's debt to the total market capitalization of the entire stock market.
P/E of the company, segment and market as a whole
P/E - PEN
Penumbra produces innovative medical devices for the treatment of strokes and other vascular diseases. This chart shows how the market perceives the potential of its products. High values โโindicate high investor expectations related to the growing demand for minimally invasive treatments and the company's unique technologies in this field.
P/E of the market segment - Therapeutic medical equipment
Penumbra is a manufacturer of innovative medical devices for stroke treatment. This chart shows the average valuation for the medical device sector. It shows the premium the market places on Penumbra for its advanced technology and rapid growth compared to more mature competitors in the medical industry.
P/E of the market as a whole
Penumbra develops and manufactures innovative medical devices for the treatment of strokes and other vascular diseases. It's a story about life-saving technologies. This chart reflects investors' overall risk appetite. For Penumbra, it's important to understand how the market views its breakthrough products and growth potential against the backdrop of overall sentiment in the healthcare and biotech sectors.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company PEN
Penumbra is a global healthcare company developing innovative medical devices for the treatment of stroke and other vascular diseases. This chart shows the high market expectations for the implementation of its technologies. The trend reflects forecasts for sales growth and adoption of its products by the medical community.
Future (projected) P/E of the market segment - Therapeutic medical equipment
Penumbra develops and manufactures innovative medical devices for the treatment of strokes and other vascular diseases. This chart reflects profitability expectations in the medical device sector. It helps understand whether investors see Penumbra's products as a technological breakthrough that will enable it to grow faster than other manufacturers.
Future (projected) P/E of the market as a whole
Penumbra, Inc. is a global healthcare company developing innovative medical devices for the treatment of stroke and other vascular diseases. This chart illustrates investor risk appetite. For a company operating in the advanced medical technology sector, it sets the scene, reflecting the market's willingness to invest in breakthrough solutions that save lives.
Profit of the company, segment and market as a whole
Company profit PEN
Penumbra develops and manufactures innovative medical devices for the treatment of strokes and other vascular diseases. The company's financial success, reflected in this chart, is directly dependent on the implementation of its technologies in clinical practice. The trend shows how demand for less invasive treatments from doctors and hospitals translates into profit growth.
Profit of companies in the market segment - Therapeutic medical equipment
Penumbra develops and manufactures innovative medical devices for the treatment of neurovascular and peripheral vascular diseases, particularly stroke. The company's success depends on the implementation of its technologies in clinical practice. This chart illustrates how breakthroughs in medical technology shape the profitability of the therapeutic device sector.
Overall market profit
Penumbra is a company developing innovative medical devices for the treatment of strokes and other vascular diseases. Its growth depends on the implementation of new technologies in hospitals and the solvency of the healthcare system. The overall economic situation, reflected in this chart, indirectly affects hospital budgets and their ability to purchase Penumbra's cutting-edge equipment.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company PEN
Penumbra is a medical device company specializing in innovative devices for the treatment of stroke and other vascular diseases. The profit forecast in this chart reflects analysts' expectations for increased adoption of its technologies in hospitals and expansion of its product line. This is a bet on innovation in healthcare.
Future (predicted) profit of companies in the market segment - Therapeutic medical equipment
Penumbra develops and manufactures innovative medical devices for the treatment of stroke and other vascular diseases. The company is a pioneer in neuro- and vascular interventions. This chart shows the revenue forecast for the therapeutic device sector, helping to assess how Penumbra's technologies impact its growth within the overall medical industry.
Future (predicted) profit of the market as a whole
Penumbra develops and manufactures innovative medical devices for the treatment of stroke and other vascular diseases. Demand for the company's products is less dependent on economic cycles, but the overall health of healthcare systems, as reflected in this chart, affects their ability to purchase new, expensive equipment.
P/S of the company, segment and market as a whole
P/S - PEN
Penumbra develops innovative medical devices for the treatment of strokes and other vascular diseases. This chart shows how investors value the company's revenue. The high sales valuation reflects the life-saving potential of its technologies and the expected growth of their application in global medicine.
P/S market segment - Therapeutic medical equipment
Penumbra, Inc. develops and manufactures innovative medical devices for the treatment of neurovascular and peripheral vascular diseases, such as stroke. The company's revenue is growing thanks to the implementation of its advanced technologies in hospitals. This chart reflects how the market values โโmedical technologies, allowing one to assess Penumbra's position in the sector.
P/S of the market as a whole
Penumbra is a global healthcare company that develops and manufactures innovative medical devices for the treatment of stroke and other vascular diseases. The company's success depends on the implementation of its technologies in clinical practice. This chart helps understand how highly the market values โโmedtech companies that are transforming treatment approaches.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company PEN
Penumbra produces innovative medical devices for the treatment of strokes and other vascular diseases. This chart shows how the market values โโthe company relative to its future sales. It reflects investor expectations for the clinical adoption of its technologies and the growing demand for minimally invasive treatments.
Future (projected) P/S of the market segment - Therapeutic medical equipment
Penumbra develops and manufactures innovative medical devices for the treatment of neurovascular and peripheral vascular diseases, including stroke. The company's products save lives and improve patient outcomes. This chart shows how the market perceives the future sales potential of its unique technologies compared to other medical device manufacturers.
Future (projected) P/S of the market as a whole
Penumbra develops and manufactures innovative medical devices for the treatment of stroke and other vascular diseases. The company's success depends on the implementation of its technologies in clinical practice. This general expectations chart for PEN is not a direct driver. Demand for its products is determined by medical needs, not the state of the economy.
Sales of the company, segment and market as a whole
Company sales PEN
This chart illustrates innovation in medicine. For Penumbra, a developer of advanced medical devices, it reflects demand for its products used to treat strokes and other vascular diseases. The growth in these indicators indicates the successful implementation of its technologies into clinical practice.
Sales of companies in the market segment - Therapeutic medical equipment
Penumbra, Inc. develops and manufactures innovative medical devices for the treatment of stroke and other vascular diseases. The company's sales are growing as its technologies are adopted by hospitals worldwide. This chart reflects how advances in minimally invasive surgery and an aging population are driving demand for Penumbra products and the entire medical device sector.
Overall market sales
Penumbra produces innovative medical devices for the treatment of strokes and other vascular diseases. The company's sales growth is driven by the introduction of new medical technologies and an aging population. Its business exemplifies the development of the high-tech healthcare sector, which is increasingly contributing to overall economic activity.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company PEN
Penumbra develops and manufactures innovative medical devices for the treatment of strokes and other vascular diseases. The company's future sales depend on the clinical adoption of its technologies and the aging population. This chart reflects analyst expectations for the development of the neuro- and vascular surgery market.
Future (projected) sales of companies in the market segment - Therapeutic medical equipment
Penumbra, Inc. develops innovative medical devices for the treatment of stroke and other vascular diseases. The forecast for the therapeutic medical device sector reflects demographic trends and technological advances, demonstrating the significant demand for the new, less invasive treatments offered by Penumbra.
Future (projected) sales of the market as a whole
Penumbra produces innovative medical devices for the treatment of strokes and other vascular diseases. Demand for its products is driven by medical needs and is not dependent on short-term economic cycles. However, the overall economic situation, as reflected here, can impact hospital budgets and their ability to purchase new, more expensive equipment.
Marginality of the company, segment and market as a whole
Company marginality PEN
Penumbra, a medical device company for the treatment of strokes and other vascular diseases, demonstrates the value of its innovations in this chart. Its high profitability is driven by the development and sale of unique devices, such as thrombectomy catheters, which save lives and are in high demand in the medical community.
Market segment marginality - Therapeutic medical equipment
Penumbra develops and manufactures innovative medical devices for the treatment of strokes and other vascular diseases. This chart shows the average profitability in the medical device sector. Technological leadership and a focus on saving lives in critical situations allow the company to maintain a strong market position and high margins.
Market marginality as a whole
Penumbra, Inc. develops and manufactures innovative medical devices for the treatment of stroke and other vascular diseases. This chart shows average profitability. In this context, Penumbra is an example of a company whose profitability is based on technological leadership in a fast-growing medical field. New products allow it to maintain high margins.
Employees in the company, segment and market as a whole
Number of employees in the company PEN
Penumbra develops and manufactures innovative medical devices for the treatment of stroke and other vascular diseases. Its team consists of engineers, scientists, and sales specialists. The growth in this chart reflects the successful launch of new products and geographic expansion of sales, which are key to growth in the medical technology sector.
Share of the company's employees PEN within the market segment - Therapeutic medical equipment
Penumbra is an innovative medical device company specializing in the development of devices for the treatment of stroke and other vascular diseases. This chart illustrates its scientific and commercial reach. It reflects the significant share of medical engineers and clinical specialists in neuro- and vascular interventional medicine that Penumbra attracts.
Number of employees in the market segment - Therapeutic medical equipment
Penumbra develops and manufactures innovative medical devices for the treatment of stroke and other vascular diseases. This chart demonstrates the growth of the high-tech medical device sector. The company creates jobs for engineers and clinicians whose innovations save lives and improve patient outcomes.
Number of employees in the market as a whole
Penumbra produces innovative medical devices for the treatment of strokes and other vascular diseases. Demand for its products is driven by medical needs, but is also influenced by the healthcare system. Stable employment, as shown in the graph, ensures a larger number of insured patients, improving access to Penumbra's cutting-edge technologies.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company PEN (PEN)
Penumbra is an innovative medical device company developing devices to treat stroke and other vascular diseases. This chart shows how the market values โโits lifesaving technologies. Its high market capitalization per employee demonstrates that its team of engineers and physicians creates unique products with tremendous value.
Market capitalization per employee (in thousands of dollars) in the market segment - Therapeutic medical equipment
Penumbra is a medical device company specializing in innovative devices for the treatment of stroke (neuro) and thrombosis (peripheral vascular). This is a high-tech medical device company. This chart shows the industry's average market capitalization per employee. It helps understand how the market values โโPenumbra's innovative R&D potential and its ability to commercialize its devices.
Market capitalization per employee (in thousands of dollars) for the overall market
Penumbra develops and manufactures innovative medical devices for the treatment of strokes and other vascular diseases. It is a high-tech company in the MedTech sector. This chart reflects the high employee rating, as its products, created by a team of engineers and physicians, have the potential to save lives and occupy a leading position in the medical device market.
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company PEN (PEN)
Penumbra is a medical device company specializing in innovative devices for the treatment of stroke (clot removal) and other vascular diseases. It's a high-tech medtech company. This chart shows how productive their R&D and sales are. It measures how much profit each employee brings in by creating and selling vital, high-margin medical devices.
Profit per employee (in thousands of dollars) in the market segment - Therapeutic medical equipment
Penumbra is a medical technology company, a leader in the R&D of stroke treatment devices. This chart shows the benchmark for "Therapeutic Equipment." The average profit per employee in this sector is high. It is an "R&D-driven business." This benchmark reflects the high margins of patented, life-saving devices that recoup the enormous R&D costs.
Profit per employee (in thousands of dollars) for the market as a whole
Penumbra produces innovative medical devices, particularly for stroke treatment. It's a high-tech business, where the company's primary value comes from research, development, and clinical trials. This chart illustrates how a successful, patented medical product can generate high margins and significant returns per employee.
Sales to employees of the company, segment and market as a whole
Sales per company employee PEN (PEN)
Penumbra produces innovative medical equipment for the treatment of strokes and other vascular diseases. This chart demonstrates the commercial success of its high-tech products. Its high revenue per employee reflects the high price and demand for its devices in clinics, indicating the effectiveness of its investment in research and development.
Sales per employee in the market segment - Therapeutic medical equipment
Penumbra produces innovative medical devices, primarily for the treatment of stroke (thrombectomy) and other vascular diseases. This is a high-tech medical device segment. This chart shows how effectively their R&D and sales teams are bringing their lifesaving technologies to market and monetizing them compared to their competitors.
Sales per employee for the market as a whole
Penumbra, Inc. is a medical device company specializing in innovative devices for the treatment of strokes (thrombectomy) and other vascular diseases. It's a knowledge-intensive business. This chart shows how much revenue each employee (engineers, R&D, sales) generates. It reflects the value of their proprietary technologies and the ability of physicians to use them to save lives.
Short shares by company, segment and market as a whole
Shares shorted by company PEN (PEN)
Penumbra produces innovative medical devices, primarily for the treatment of strokes (aspiration catheters) and other vascular diseases. This chart shows bearish sentiment. Investors betting on the stock may be concerned about increased competition in this lucrative niche or potential regulatory scrutiny related to the safety or marketing of its products.
Shares shorted by market segment - Therapeutic medical equipment
Penumbra produces innovative medical equipment, particularly for the treatment of strokes (thrombectomy) and vascular diseases. This chart shows overall short positions in the medical equipment sector. If it's high, investors may be concerned that hospitals are cutting their budgets for new equipment purchases or that regulators (like the FDA) are tightening requirements.
Shares shorted by the overall market
Penumbra (PEN) is an innovative company that produces medical devices for the treatment of strokes (neuro) and thrombosis (vascular). This chart shows the overall level of fear. When pessimism increases, investors seek "safety." PEN is that. Stroke treatment is an emergency procedure that is not affected by recessions. Demand for their products is completely non-cyclical.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator PEN (PEN)
Penumbra is an innovative medical technology company creating life-saving devices for stroke patients (clot removal). This chart measures the strength of the trend. A successful launch of a new thrombectomy system or a strong sales report could trigger euphoria, pushing this chart into overbought territory (above 70).
RSI 14 Market Segment - Therapeutic medical equipment
Penumbra (PEN) is a stroke savior. They are a leader in the development of innovative catheters for the aspiration (sucking) of blood clots from cerebral vessels. This indicator measures the "temperature" of the sector. It helps us understand: is PEN overheated by its "revolutionary" technology or is the entire "neuromedical equipment" sector overbought?
RSI 14 for the overall market
Penumbra (PEN) is a medical device company specializing in innovative devices for the treatment of stroke and other vascular diseases. This indicator of overall risk appetite is important. Medical device stocks, especially innovative ones like PEN, require investors to have faith in the technology. In times of panic, investors prefer proven companies with profits over growth stories.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast PEN (PEN)
Penumbra is an innovative medical device company. They develop and manufacture devices (catheters) for minimally invasive stroke treatment (thrombectomy) and vascular diseases. This chart is a collective 12-month forecast from analysts. It reflects their expectations for growth in thrombectomy procedures and the adoption of their new products.
The difference between the consensus estimate and the actual stock price PEN (PEN)
Penumbra is an innovative medical device company. They develop and market devices (catheters) for minimally invasive treatment of strokes (blood clot removal from the brain) and other vascular diseases. This chart shows analysts' confidence in their cutting-edge technology. It reflects the gap between the consensus forecast and the current price.
Analyst consensus forecast for stock prices by market segment - Therapeutic medical equipment
Penumbra is an innovative medical device company developing tools for minimally invasive treatments (such as clot aspiration) for strokes and thrombosis. This chart shows general expectations for the medical device sector. It reflects whether experts believe the market for high-tech surgical procedures will grow.
Analysts' consensus forecast for the overall market share price
Penumbra is a high-tech medical device company specializing in devices to treat strokes (thrombectomy) and other vascular conditions. Market expectations, as shown in this chart, have little impact on them. Demand for their products is determined not by economics, but by the number of strokes that occur in any given phase of the cycle.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index PEN
Penumbra is an innovative MedTech company developing minimally invasive devices. Their key markets are neurosurgery (blood clot removal during stroke) and vascular diseases. This chart evaluates their innovation, measuring the rate of hospital adoption of their new products and their ability to capture market share in stroke treatment.
AKIMA Market Segment Index - Therapeutic medical equipment
Penumbra is an innovative medical technology company focused on minimally invasive vascular treatments and a leader in clot removal devices (for stroke and thrombosis). This composite metric evaluates companies. The graph shows the sector average. This benchmark: how does Penumbra's technological leadership in thrombectomy differentiate it from the average competitor?
The AKIM Index for the overall market
Penumbra is a medtech company specializing in innovative interventional devices, primarily for stroke treatment (thrombectomy). This chart, which reflects the market average, provides context. It helps assess how this growth story in the defensive healthcare sector compares to the overall macroeconomic trends impacting markets.